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The epidemiology of thyroid disorders is significantly associated with iodine supply. In 1999, Slovenia increased iodine 
content in kitchen salt from 10 mg to 25 mg of potassium iodide per kg of salt. According to the WHO criteria, Slovenia 
shifted from a mildly iodine-deficient country to a country with adequate iodine intake. Ten years after the increase in 
iodine intake, the incidence of diffuse goitre and thyroid autonomy decreased. Now patients with diffuse goitre and thyroid 
autonomy reach older age than the patients before the increase in iodine intake. In addition, patients with thyroid autonomy 
are less frequently hyperthyroid than ten years ago and iodine-induced hyperthyroidism is less severe. The incidence of 
highly malignant thyroid carcinoma has also dropped. However, the incidence of Hashimoto’s thyroiditis increased, most 
probably in genetically predisposed individuals. Over the last ten years, many animal and in vitro studies evaluated the 
effects of endocrine disrupting chemicals (EDC) on various aspects of the thyroid function. They mostly studied the 
effects of polychlorinated biphenyls (PCBs) and dioxins, brominated flame retardants, phthalates, bisphenol A, 
perfluorinated chemicals, and perchlorate. However, human studies on the effects of EDCs on the thyroid function are 
very scarce, especially the long-term ones. What they do suggest is that PCBs and dioxins interfere with the transport of 
thyroid hormones and adversely affect the thyroid function. Many authors agree that iodine deficiency predisposes the 
thyroid gland to harmful effects of EDCs. Therefore the effects of EDCs in iodine-deficient areas could be more severe 
than in areas with adequate iodine intake.
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Beside diabetes, the most frequent disorders of 
endocrine glands are those affecting the thyroid gland. 
Genetic factors largely contribute to the occurrence of 
various thyroid diseases such as Graves’ disease, 
Hashimoto’s thyroiditis, or goitre (1). However, their 
prevalence is also strongly associated with iodine supply 
in the environment (2), as the thyroid gland requires 
adequate amounts of iodine to function properly (3). Of all 
endocrine glands, the thyroid exhibits a unique connection 
with the environment. It is sensitive to iodine intake and 
the influence of endocrine disrupting chemicals (EDC) (4). 
The aim of this article is to review the effects of 
environmental factors on the thyroid function and size with 
the focus on iodine intake and EDCs.
Iodine and thyroid hormones
Ingested iodine is absorbed as I- in the stomach and 
upper small intestine. Adult body contains around 15 to 
20 mg of iodine, of which 70 to 80 % is in the thyroid gland 
(5, 6). Iodine concentration within thyroid cells is 20 to 40 
times higher than in the blood. The ability of thyroid cells 
to accumulate iodine against the concentration gradient is 
enabled by the transport protein called sodium (Na+)-iodide 
(I-) symporter (NIS). NIS combines the transport of Na+ 
along the concentration gradient with the transport of I- 
against the concentration gradient using the energy from 
adenosine triphosphate (ATP) obtained from the activity of 
Na+-potassium (K+)-ATPase (7). With the help of thyroid 
peroxidise (TPO), I- is first oxidised, then integrated into 
glycoprotein thyroglobulin (Tg) as monoiodotyrosine (MIT) 
and diiodotyrosine (DIT), which are finally coupled into 
thyroxine (T4) or triiodothyronine (T3) (8). The accumulation 
of I- and the synthesis of thyroid hormones is regulated by 
the thyroid-stimulating hormone (TSH, aka thyrotropin), 
secreted from the pituitary gland (9), as well as by iodine 
itself (10).
The thyroid gland produces all T4 and only 20 % of T3. 
The remaining T3 originates from the conversion of weakly 
active T4 into very active T3 by enzymes deiodinases, which 
are present in several tissues (11). To a high degree T4 and 
T3 bind to transport proteins in serum. Less than 1 % of T4 
and T3 circulate as free thyroxine (fT4) and free 
triiodothyronine (fT3) (12). However, only free thyroid 
hormones are active and are transported to different cells, 
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where they bind to nuclear, plasma membrane, cytoplasm, 
and mitochondrial receptors and perform their genomic and 
non-genomic actions (13, 14). Thyroid hormones regulate 
metabolism and are especially important for the development 
of human brain during foetal life and early childhood (15). 
In areas with severe iodine deficiency, lack of iodine during 
pregnancy may cause iodine-deficiency disorders in 
offspring (16).
Iodine supply
In most developed countries the main source of iodine 
is iodised kitchen salt, since iodine content in soil, and, 
consequently, in ground water, vegetables, and meat is too 
low to meet daily needs. The World Health Organization 
(WHO) recommends iodisation of kitchen salt with 20 to 
40 mg of potassium iodide per kg of salt (3). Daily intake 
of iodine for adults should reach 150 µg. For pregnant and 
lactating women, a higher daily intake of around 250 µg is 
recommended. In pregnancy, more thyroid hormones are 
produced because of increased levels of transport proteins 
(17). Additionally, iodine is partly transported to the foetus 
via placenta. During lactation, adequate iodine intake is 
especially important since a breastfed child depends only 
on iodine from mother’s milk.
As iodine intake cannot be measured directly, and iodine 
is largely secreted in urine, its urinary concentration makes 
a good estimate of the intake. According to the WHO 
criteria, urinary iodine concentration (UIC) between 50 and 
99 µg L-1 suggests mild iodine deficiency, 20 to 49 µg L-1 
moderate deficiency, and below 20 µg L-1 severe deficiency 
(3). A great portion of the world’s population still lives in 
areas where iodine supply is deficient. Even in Europe, 
countries without stable and mandatory iodisation of kitchen 
salt can have areas of mild or moderate iodine deficiency.
Iodine and thyroid disorders
Optimal iodine intake lies within a relatively narrow 
range between 150 and 250 µg a day (3). Too low an intake 
may lead to iodine deficiency disorders and enlarged thyroid 
gland, known as goitre. Intake which is too high leads to 
autoimmune thyroid disorders and hypothyroidism. In 
addition, any change in iodine supply is associated with a 
change in the epidemiology of thyroid disorders. One such 
epidemiological change occurred with the increase in iodine 
supply in Slovenia in 1999.
From 1953 to 1999, kitchen salt in Slovenia had been 
iodised with 10 mg of potassium iodide per kg. In 1991 to 
1994, we measured UIC in a population of 1740 
schoolchildren to be 82.9 µg g-1 of creatinine (18, 19), which 
suggested a mild iodine deficiency. The average volume of 
their thyroid gland, measured by ultrasound, was 7.2 mL.
In the early 1999, kitchen salt iodisation increased to 
25 mg (range: 20 to 30 mg) of potassium iodide per kg of 
salt. Measurements since 1999 show a daily intake of 9.4 g 
of kitchen salt in girls and 11.5 g in boys (20) and 9.9 g in 
women and 13.0 g in men (21). As soon as 2003, UIC in 
schoolchildren increased to 148 µg L-1, which suggests 
adequate iodine intake (19). In pregnant women, it was also 
high enough - 170.5 µg g-1 of creatinine in the third trimester, 
and 144 µg g-1 of creatinine after childbirth (22). The volume 
of the thyroid gland in schoolchildren decreased to 5.8 mL 
(19).
From 1999 to 2009, the incidence of diffuse goitre 
dropped over 80 % (19). In 2009, patients with newly 
diagnosed diffuse goitre were significantly older than those 
diagnosed with the disease in 1999 (53 vs. 38 years, 
respectively). This clearly suggests that younger generations 
benefited from adequate iodine supply. After all, older 
patients had lived in iodine deficiency longer than the 
younger subjects.
Thyroid autonomy is caused by various mutations of 
TSH receptor and/or signalling proteins (23). Autonomous 
thyroid cells produce thyroid hormones irrespective of 
regulation by TSH. The incidence of thyroid autonomy has 
been reported to be higher in iodine-deficient than in iodine-
sufficient areas (3). From 1999 to 2009, the incidence of 
thyroid autonomy in Slovenia decreased by 27 % (19). 
Furthermore, in 2009, patients with the newly diagnosed 
thyroid autonomy were older and less frequently 
hyperthyroid than patients in 1998. This again confirms the 
effects of iodine deficiency are time-dependent (24). 
Literature data regarding iodine supply and thyroid 
autonomy are scarce and inconclusive. Our data are in 
accordance with those from Switzerland (25, 26).
Excessive iodine intake is usually related to the 
antiarrhythmic drug amiodarone or iodinated contrast media 
in radiology. In predisposed individuals, such as patients 
with thyroid autonomy, iodine excess most frequently 
provokes hyperthyroidism. By contrast, in patients with 
Hashimoto’s thyroiditis, iodine excess may induce 
hypothyroidism. Andersen et al. (27) reported that in areas 
with iodine deficiency iodine excess more often causes 
hyperthyroidism while in areas with adequate iodine intake 
it may cause hypothyroidism. Ten years after the increase 
in salt iodisation, our results show a higher incidence of 
iodine-induced hypothyroidism, a less severe iodine-
induced hyperthyroidism, and a shorter duration of 
treatment of hyperthyroidism, which are all clinical 
improvements over the earlier period (28).
Literature data about iodine-induced thyroid disorders 
with respect to iodine supply are very scarce. In Slovenia, 
we have observed a lower incidence of the most malignant 
anaplastic thyroid carcinoma between 1998 and 2008 than 
between 1972 and 1998 (29). After the increase in iodine 
supply, patients with the newly diagnosed anaplastic thyroid 
carcinoma were older than before the increase. Again, it 
seems that younger generations have benefited from 
adequate iodine supply.
As for Hashimoto’s thyroiditis, its incidence in Slovenia 
more than doubled after the increase in iodine supply (19). 
These findings confirm Iranian reports of up to four-fold 
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increase in the prevalence of thyroid autoantibodies after 
the improvement of iodine prophylaxis in iodine-deficient 
areas (30). Other authors reported the prevalence of thyroid 
autoantibodies of around 11 % in iodine deficiency (31), 
18 % in iodine sufficiency (32), and around 25 % in 
excessive iodine intake (33, 34). Many tried to elucidate 
the influence of iodine supply on thyroid autoimmunity. 
Some suggest that higher intake of iodine may increase the 
iodination of thyroglobulin and the level of reactive oxygen 
species within thyroid cells, thus promoting immunogenicity 
(35, 36). Others believe that iodine may have a toxic effect 
on thyroid cells and stimulate the cells of the immune 
system (1, 37).
Whichever the reason, a change from mild iodine 
deficiency to iodine sufficiency is associated with many 
beneficial effects with regard to the incidence and severity 
of various thyroid disorders.
Endocrine disrupting chemicals
Endocrine disrupting chemicals most often affect the 
NIS, TPO, transport protein transthyretin, deiodinases, and 
thyroid hormone receptors (4, 38).
Polychlorinated biphenyls (PCBs) and dioxins are 
persistent environmental pollutants, which accumulate in 
the food chain and - due to lipophilic properties - in the 
human body, in spite of the ban from the 1970s. The 
chemical structure of PCBs and dioxins is similar to the 
chemical structure of thyroid hormones, as they all have 
two linked phenyl rings. PCBs displace T4 from transport 
proteins (39), decrease the serum levels of thyroid hormones 
and, accordingly, increase the serum levels of TSH (40, 41). 
However, Goldey et al. (42) have also reported serum T4 
drop without an increase in TSH. Interestingly, hydroxylated 
PCBs were able to increase the activity of thyroid receptors 
in rats (43). In vitro, PCBs bind to transport proteins and 
inhibit the binding of T3 to the receptor (44, 45). In humans, 
exposure to PCBs was associated with thyroid antibodies 
and hypothyroidism (1). All in all, it seems that PCBs and 
dioxins affect the thyroid function adversely.
Polybrominated diphenyl ethers (PBDEs) are used as 
flame retardants and also have chemical resemblance with 
the thyroid hormones with two halogenated phenyl rings 
(40). Since PBDEs are lipophilic, they accumulate in several 
human tissues (46). Human studies with PBDEs are very 
scarce. In animals, PBDEs decreased the levels of thyroid 
hormones (47), and affected binding proteins, thyroid 
hormone receptors, and hepatic clearance (48, 49).
Pesticides are still amply present in the environment. 
In animal studies, they adversely affected thyroid hormone 
levels (50). In vitro, phenol compounds inhibited TPO (51). 
Relevant human studies are not available.
In humans as well as in animals, perfluorooctanoate 
adversely affects fT4 (52, 53). In the National Health and 
Nutrition Examination Survey carried out in the United 
States (54), individuals with high levels of perfluorooctanoic 
acid more frequently reported treated thyroid disease.
Human studies with phthalates are very scarce. In 
children, they negatively correlated with serum T3 (55). A 
similar correlation was found between phthalates and fT4 
in men and pregnant women (56, 57).
In vitro, bisphenol A (BPA) binds to thyroid hormone 
receptors and therefore disrupts thyroid hormone activity 
(58). In rats, developmental exposure to BPA caused a 
condition similar to thyroid resistance syndrome, with 
increased serum levels of T4 and normal or slightly increased 
levels of TSH, indicating that BPA could act as a specific 
antagonist of thyroid hormone receptor β, which is known 
to be impaired in the thyroid resistance syndrome (59, 60).
Perchlorate in drinking and irrigation waters and in food 
- a problem particularly familiar to the USA - reduces iodide 
uptake into the thyroid cells (38, 61). In the general 
population of women, urinary levels of perchlorate 
correlated with serum TSH levels (62). In women with 
urinary iodine below 100 µg L-1 and in women who smoked 
this correlation was even stronger, since smokers have 
higher serum levels of thiocyanates than non-smokers, and 
thiocyanate reduces iodide uptake (63).
For many other EDCs human studies are not available. 
In vitro and animal studies indicate significant effects on 
the thyroid function, but solid data on humans are needed 
for a more objective view of EDCs. To summarise, potential 
EDCs are numerous, human studies with EDCs are scarce, 
exposure to EDCs is universal, and long-term effects are 
very difficult to study. Therefore, a long-term follow-up of 
larger groups of exposed individuals would bring valuable 
information about the effects of EDCs on the thyroid 
function.
CONCLUSION
Changes in iodine supply significantly reflect on the 
epidemiology of thyroid disorders in an area. Optimum 
iodine intake - which lies within a relatively narrow range 
- is the prerequisite for the normal growth and function of 
the thyroid gland. In contrast, iodine deficiency makes the 
thyroid gland more sensitive to various adverse effects, 
including the effects of EDCs. The Slovenian example 
confirms the importance of a sustained and mandatory 
iodination programme in abating thyroid disorders.
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Epidemiološki trendi bolezni ščitnice, ki so povezane z jodom: primer Slovenije
Epidemiologija bolezni ščitnice je pomembno povezana z jodno preskrbo. V Sloveniji smo leta 1999 zvečali vsebnost 
joda v kuhinjski soli z 10 mg na 25 mg kalijevega jodida na kg soli. Glede na kriterije SZO smo se iz države z blagim 
pomanjkanjem joda spremenili v državo z ustreznim vnosom joda. Ugotovili smo, da se je v desetih letih po zvečanju 
jodne preskrbe zmanjšala pojavnost difuzne golše in avtonomnega tkiva v ščitnici. Bolniki z difuzno golšo in avtonomnim 
tkivom so sedaj starejši kot pred zvečanjem jodne preskrbe. Poleg tega so bolniki z avtonomnim tkivom redkeje hipertirotični 
kot pred desetimi leti, hipertiroza, ki je posledica čezmernega vnosa joda, pa je manj izražena. Zmanjšala se je pojavnost 
najbolj maligne oblike ščitničnega karcinoma. Povečala se je pojavnost Hashimotovega tiroiditisa, verjetno pri genetsko 
predisponiranih posameznikih. V zadnjem desetletju so v številnih raziskavah na živalih in v raziskavah in vitro ugotavljali 
vpliv kemijskih povzročiteljev hormonskih motenj (KPHM) na različne vidike ščitnične funkcije. Najpogosteje testirani 
KPHM so bili poliklorirani bifenili (PCB) in dioksini, bromirani zaviralci gorenja, ftalati, bisfenol A, perfluorirane 
kemikalije in perklorat. Vendar pa so raziskave o učinkih KPHM na delovanje ščitnice pri ljudeh, zlasti dolgoročne 
raziskave, zelo redke. Zdi se, da zlasti PCB in dioksini vplivajo na transport ščitničnih hormonov in negativno učinkujejo 
na delovanje ščitnice. Številni avtorji menijo, da pomanjkanje joda poveča dovzetnost ščitnice za škodljive učinke KPHM. 
Torej bi lahko bili škodljivi učinki KPMH na področjih pomanjkanja joda resnejši kot na področjih zadostnega vnosa 
joda. 
KLJUČNE BESEDE: avtonomno tkivo ščitnice; difuzna golša; dioksini; Hashimotov tiroiditis; hipertiroza zaradi 
čezmernega vnosa joda; kemijski povzročitelji hormonskih motenj; poliklorirani bifenili; preskrba z jodom
